EDGAR Filing Agent Form List
CIK: 0001636282
Form Type:
Year
| Form | Filer/Owner | Description | Subject Company | Date | Actions |
|---|---|---|---|---|---|
| 10-Q | Spyre Therapeutics, Inc. | Quarterly report pursuant to Section 13 or 15(d) | 08/05/2025 | ||
| S-8 | Spyre Therapeutics, Inc. | Initial registration statement for securities to be of... | 08/05/2025 | ||
| 8-K | Spyre Therapeutics, Inc. | Current report filing | 08/05/2025 | ||
| 4 | Kiselak Tomas | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Fairmount Funds Management Llc | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Harwin Peter Evan | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Spyre Therapeutics, Inc. | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Stelzer Laurie | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Stelzer Laurie | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| 4 | Milligan Sandra | Statement of changes in beneficial ownership of securi... | Spyre Therapeutics, Inc. | 06/02/2025 | |
| Load More | |||||
